ABOUT

Thierry Drugeot has more than 27 years of experience in diverse pharmaceutical environments. He had the opportunity to start and grow numerous businesses in Europe, of which oncology and rare diseases, especially during his stay at Pfizer (20 years). Further to Pfizer, he joined the Recordati Group where he led the French affiliate (300+ employees). He is also very committed as Business Angel in several start-ups in the healthcare sector as investor and board member.

Thierry Drugeot is a doctor in Veterinary medicine (DVM), graduated in business administration from IAE Nantes and earned a certificate in Finance from INSEAD.

SPECIALIZATIONS

General Management, commercial development, Finance.

FUNCTION

CEO

ABOUT

Franck Molina joined Parkes-Davies (Pfizer) in 1996. He joined CNRS in 1999 and led since 2007 SYSDIAG private / public laboratory dedicated to innovation in medical diagnosis. He is also coordinator of the diagnostic industry competitiveness cluster Eurobiomed and President of the European alliance of medical diagnosis in Brussels (EDCA). His activities led to 80 international publications and several patents including some during operation.

SPECIALIZATIONS

biocomputing for systems and synthetic biology

FUNCTIONS

Technology director

ABOUT

Marc Ychou is director of Medical Oncology department of the ICM Val-d'Aurelle and CHU Montpellier. Ychou Marc was recently named director of cancer integrated research center of Montpellier (SIRIC) where he coordinates one of the four SIRIC research programs to identify new biomarkers and new therapeutic targets in colorectal cancer. Marc Ychou is a international opinion leader in digestive oncology and author of over one hundred publications and is a consultant for several major pharmaceutical companies.

SPECIALIZATIONS

Digestive oncology, Gestion & comptability.